iRay Group (SHA:688301)
China · Delayed Price · Currency is CNY 97.15
-3.79 (-3.75%)
Aug 24, 2026, 3:00 PM CST
iRay Group Market Cap
iRay Group has a market cap or net worth of 30.43 billion as of August 24, 2026. Its market cap has increased by 36.25% in one year.
Market Cap
30.43B
Enterprise Value
30.64B
Revenue
2.86B
Ranking
n/a
PE Ratio
40.36
Stock Price
97.15
ChartMarket Cap Chart
Since September 18, 2020, iRay Group's market cap has increased from 11.61B to 30.43B, an increase of 162.03%. That is a compound annual growth rate of 17.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 24, 2026 | 30.43B | 42.52% |
| Dec 31, 2025 | 21.35B | 56.38% |
| Dec 31, 2024 | 13.66B | -58.82% |
| Dec 29, 2023 | 33.16B | -0.38% |
| Dec 30, 2022 | 33.28B | -7.67% |
| Dec 31, 2021 | 36.05B | 189.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 18, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Gan & Lee Pharmaceuticals. | 40.73B |
| Intco Medical Technology | 31.36B |
| Andon Health | 29.65B |
| Imeik Technology Development | 27.84B |
| Zhende Medical | 21.58B |
| Jiangsu Hualan New Pharmaceutical Material | 17.49B |
| Winner Medical | 16.90B |
| Shenyang Xingqi Pharmaceutical | 14.20B |